Chris Kosel, the VP-Corp Controller and CAO of $LII, sold 254 shares of the company on 02-04-2026 for an estimated $136,271. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.9% of their shares of this class of stock. Following this trade, they now own 1,090 shares of this class of $LII stock.
$LII Insider Trading Activity
$LII insiders have traded $LII stock on the open market 41 times in the past 6 months. Of those trades, 0 have been purchases and 41 have been sales.
Here’s a breakdown of recent trading of $LII stock by insiders over the last 6 months:
- KAREN H QUINTOS has made 0 purchases and 38 sales selling 1,447 shares for an estimated $880,059.
- CHRIS KOSEL (VP-Corp Controller and CAO) has made 0 purchases and 2 sales selling 554 shares for an estimated $313,829.
- TODD J TESKE sold 600 shares for an estimated $295,110
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$LII Hedge Fund Activity
We have seen 309 institutional investors add shares of $LII stock to their portfolio, and 334 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- M&T BANK CORP added 3,523,561 shares (+566488.9%) to their portfolio in Q4 2025, for an estimated $1,710,970,750
- MATHER GROUP, LLC. removed 1,065,654 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $517,460,269
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 327,481 shares (-98.5%) from their portfolio in Q3 2025, for an estimated $173,355,342
- CITADEL ADVISORS LLC removed 288,522 shares (-50.9%) from their portfolio in Q3 2025, for an estimated $152,732,005
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 159,374 shares (+54.2%) to their portfolio in Q3 2025, for an estimated $84,366,220
- RAKUTEN INVESTMENT MANAGEMENT, INC. added 152,206 shares (+5198.3%) to their portfolio in Q3 2025, for an estimated $80,571,768
- HOLOCENE ADVISORS, LP added 125,005 shares (+inf%) to their portfolio in Q3 2025, for an estimated $66,172,646
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$LII Revenue
$LII had revenues of $1.2B in Q4 2025. This is a decrease of -11.15% from the same period in the prior year.
You can track LII financials on Quiver Quantitative's LII stock page.
$LII Analyst Ratings
Wall Street analysts have issued reports on $LII in the last several months. We have seen 1 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Morgan Stanley issued a "Underweight" rating on 10/23/2025
- JP Morgan issued a "Underweight" rating on 10/23/2025
- Oppenheimer issued a "Outperform" rating on 09/17/2025
To track analyst ratings and price targets for $LII, check out Quiver Quantitative's $LII forecast page.
$LII Price Targets
Multiple analysts have issued price targets for $LII recently. We have seen 9 analysts offer price targets for $LII in the last 6 months, with a median target of $541.0.
Here are some recent targets:
- Betsy Graseck from Morgan Stanley set a target price of $450.0 on 02/02/2026
- Deane Dray from RBC Capital set a target price of $534.0 on 01/29/2026
- Joseph O'Dea from Wells Fargo set a target price of $520.0 on 01/29/2026
- Stephen Tusa from JP Morgan set a target price of $541.0 on 01/16/2026
- Julian Mitchell from Barclays set a target price of $667.0 on 01/07/2026
- Amit Mehrotra from UBS set a target price of $530.0 on 01/05/2026
- Brett Linzey from Mizuho set a target price of $565.0 on 10/17/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
